Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-22-022683

EVP and General Counsel sold 33,798 shares at an average $77.89 ($2,632,594)

  • EVP and General Counsel acquired 28,558 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Basil Michelle L EVP and General Counsel 2022-09-15 Option exercise +11,154 $38.43 $428,648 51,789 D: show line 1 in the form
Basil Michelle L EVP and General Counsel 2022-09-15 Option exercise +14,231 $41.64 $592,579 66,020 D: show line 2 in the form
Basil Michelle L EVP and General Counsel 2022-09-15 Option exercise +3,173 $56.57 $179,497 69,193 D: show line 3 in the form
Basil Michelle L EVP and General Counsel 2022-09-15 Sale −27,769 $77.76 $2,159,317 41,424 D: show line 4 in the form
Basil Michelle L EVP and General Counsel 2022-09-15 Sale −6,029 $78.50 $473,277 35,395 D: show line 5 in the form
Open-market sales · 33,798 sh · avg $77.89 · $2,632,594

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Basil Michelle L EVP and General Counsel 2022-09-15 Option exercise · Non-qualified Stock Option (Right to Buy) −11,154 3,464 D: show line 6 in the form
Basil Michelle L EVP and General Counsel 2022-09-15 Option exercise · Non-qualified Stock Option (Right to Buy) −14,231 4,213 D: show line 7 in the form
Basil Michelle L EVP and General Counsel 2022-09-15 Option exercise · Non-qualified Stock Option (Right to Buy) −3,173 13,564 D: show line 8 in the form
Loading xslF345X03/form4.xml…